§Why CasetextPricing

Foreign-Trade Zone (FTZ) 230; Authorization of Production Activity; Patheon Softgels; (Pharmaceutical Products); High Point, North Carolina

89 Fed. Reg. 83456 (Oct. 16, 2024)

Foreign-Trade Zone (FTZ) 230; Authorization of Production Activity; Patheon Softgels; (Pharmaceutical Products); High Point, North Carolina

Download PDF
Federal RegisterOct 16, 2024
89 Fed. Reg. 83456 (Oct. 16, 2024)
Document Headings

Document headings vary by document type but may contain the following:

  • the agency or agencies that issued and signed a document
  • the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  • the agency docket number / agency internal file number
  • the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions

    • See the Document Drafting Handbook for more details.

    Department of Commerce Foreign-Trade Zones Board
  • [B-31-2024]

    • On June 12, 2024, The Piedmont Triad Partnership, grantee of FTZ 230, submitted a notification of proposed production activity to the FTZ Board on behalf of Patheon Softgels, within Subzone 230C, in High Point, North Carolina.

    The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (89 FR 51873, June 20, 2024). On October 10, 2024, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including section 400.14.

    Dated: October 10, 2024.

    Elizabeth Whiteman,

    Executive Secretary.

    [FR Doc. 2024-23819 Filed 10-15-24; 8:45 am]

    BILLING CODE 3510-DS-P